Discovery of a Potent 9‐Deazaxanthine‐based Agent for the Treatment of Obesity‐Related Non‐alcoholic Fatty Liver Disease

Publisher: John Wiley & Sons Inc

E-ISSN: 1747-0285|86|1|846-859

ISSN: 1747-0277

Source: CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.86, Iss.1, 2015-07, pp. : 846-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content